Shares of Jaguar Animal Health Inc (NASDAQ:JAGX) have been given an average broker rating score of 1.50 (Buy) from the two analysts that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company.
Brokerages have set a 1 year consensus price objective of $6.75 for the company and are expecting that the company will post ($0.40) earnings per share for the current quarter, according to Zacks. Zacks has also given Jaguar Animal Health an industry rank of 98 out of 265 based on the ratings given to its competitors.
Several equities analysts have recently weighed in on the company. Zacks Investment Research downgraded Jaguar Animal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, August 10th. Aegis restated a “buy” rating and issued a $10.00 target price on shares of Jaguar Animal Health in a research report on Monday, June 13th.
Shares of Jaguar Animal Health (NASDAQ:JAGX) traded down 0.14% during midday trading on Wednesday, hitting $1.14. The company’s stock had a trading volume of 19,005 shares. The firm has a 50-day moving average of $1.30 and a 200 day moving average of $1.58. The firm’s market cap is $12.68 million. Jaguar Animal Health has a 12-month low of $1.09 and a 12-month high of $4.70.
Jaguar Animal Health Company Profile
Jaguar Animal Health, Inc is an animal health company focused on developing and commercializing gastrointestinal products for companion and production animals, and horses. The Company is developing a pipeline of prescription drug product candidates and non-prescription (non-drug) products. Its pipeline includes prescription drug product candidates for over eight indications across various species and non-prescription products targeting over seven species.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Jaguar Animal Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.